|Almut Winterstein, RPh, Ph.D., FISPE
Professor and Chair
Office: HPNP Room 3336
|Dr. Winterstein’s research program focuses on the evaluation and prediction of drug safety and effectiveness in real-world populations and on devising ways to improve medication use. Clinical areas of interest include pediatrics and pregnancy, psychopharmacology and treatment and prevention of infectious disease.|
|Joshua Brown, Pharm.D., Ph.D., M.S.
Office: HPNP 3320
|Dr. Brown’s research is in the field of comparative effectiveness and safety research focusing on anticoagulants, hematology and cardiology, and in health care policy evaluation|
|Vakaramoko Diaby, Ph.D., M.Sc.
Office: HPNP Room 3317
|Dr. Diaby’s research interests are in the field of economic evaluation, decision analytic modeling, health technology assessment, or HTA, and priority setting using multi-criteria decision analysis, or MCDA.|
|Randy Hatton, Pharm.D, BPharm, FCCP, BCPS
Office: HPNP Room 2331
|Dr. Hatton’s research interests include evidence-based practice, patient safety and over-the-counter products.|
|Robert P. Navarro, Pharm.D.
Office: HPNP 2338
|Dr. Navarro’s research interests include real-world drug value assessments, performance-based risk-sharing arrangements with pharmaceutical manufacturers and value-based drug formulary management in various patient populations, as well as benefits and risks of public pharmaceutical policy on patient drug access, affordability and outcomes experiences.|
|Haesuk Park, Ph.D.
Office: HPNP Room 3325
|Dr. Park’s research program focuses on the evaluation of economic and health outcomes of medications and pharmaceutical care services as well as policy associated with the use of pharmaceuticals.|
|Richard Segal, Ph.D.
Associate Dean, Professor, and Graduate Program Director
Office: HPNP Room 4332C
|Dr. Segal’s research focuses on improving the quality and safety of the medication use process, with a particular emphasis on improving prescribing practices and in creating collaborative practice models to improve medication use by patients|
|Yu-Jung “Jenny” Wei, Ph.D.
Office: HPNP 3321
|Dr. Wei’s research programs focus on questions surrounding the effectiveness, safety and quality of medication use in elderly patients with chronic conditions, especially those in nursing home settings.|
|Hong Xiao, Ph.D.
Office: HPNP 3338
|Dr. Xiao’s research interests include access to and utilization of pharmaceutical and/or health services and related clinical, economic and humanistic outcomes with a focus on disparities in cancer outcomes.|